The breakthrough discovery that could reverse deadly pancreatic cancer

In an article featured by Yahoo News, it discusses a new therapy approached to battle pancreatic cancer.

Pancreatic cancer may be reversed by a so-called “gremlin” therapy, scientists have found in a landmark discovery.

Early findings suggest a gene and a protein known as Grem1, or “gremlin”, could be pivotal in controlling and combatting the illness.

Pancreatic cancer has a notoriously high mortality rate, with just seven per cent of patients surviving for five years or more. Every year, more than 10,000 people in the UK are diagnosed with the disease, with around 9,000 deaths.

Scientists from the Institute of Cancer Research conducted studies in mice and on mini pancreases made in a laboratory, where they manipulated the level of the gremlin protein in the system.

This article continues to discuss ways this therapy can ‘reverse the fate’ of dangerous cells, how it is an important and fundamental discovery, and enhances understanding of origins of pancreatic cancer.  To read the full article, click here.